Wird geladen...
Differences in reimbursement listing of anticancer therapies in China: an observational study
OBJECTIVE: Access to highly priced anticancer medications usually requires insurance coverage. A first step towards coverage of such medications is their inclusion in reimbursement lists. We assessed listing for reimbursement in China between 2009 and 2018 of anticancer medications on the WHO’s Esse...
Gespeichert in:
| Veröffentlicht in: | BMJ Open |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMJ Publishing Group
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6955534/ https://ncbi.nlm.nih.gov/pubmed/31911513 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-031203 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|